Schrodinger partners with Bristol Myers to deploy Bunsen AI co-scientist in drug discovery
SDGR•Strategic collaboration with Bristol Myers Squibb
Schrodinger signed a strategic collaboration and software agreement with Bristol Myers Squibb to deploy its agentic AI co-scientist, Bunsen, across BMS research.
The deal expands BMS use of Schrodinger’s computational platform, aiming to speed molecule prioritization and drug-discovery decisions.
The parties will co-develop new Bunsen functionality, integrating large-scale chemical exploration workflows with the RetroSynth AI synthesis-planning platform.
